Furuya Lab banner image
FURUYA LABORATORY
Precision cancer prevention & biomarker-driven early detection

We develop and validate non-invasive biomarkers and integrative multi-omics strategies to enable earlier detection, risk stratification, and precision treatment of cancer—with a major focus on bladder cancer and upper-tract urothelial carcinoma.

Urine biomarkers Multiplex protein assays Radiogenomics Spatial biology Clinical translation

Team

Hideki Furuya headshot

Hideki Furuya, PhD

Principal Investigator

Translational cancer researcher focused on biomarker-driven precision prevention, early detection, and clinically scalable assay development.

I received my PhD from Meiji University (Tokyo, Japan) and completed postdoctoral training at the Medical University of South Carolina and the University of Hawaiʻi Cancer Center. I later joined UHCC as an Assistant Professor before moving to Cedars-Sinai Medical Center, where I opened my independent laboratory.

My research integrates human cohorts, multi-omics, spatial biology, and rigorous analytical validation to develop non-invasive diagnostic strategies that improve risk stratification and patient care.

Lab members

Photo

We’re recruiting

Postdoctoral fellows

Biomarkers, assay development and validation, multi-omics integration, spatial biology, and radiogenomics.

See openings

Photo

We’re recruiting

Research staff & trainees

Research associates/technicians, graduate and undergraduate trainees, and computational collaborators.

Get in touch